Search: 
You do not have permission to access this chart.
Please Sign Up or Login
News for Milestone Pharmaceuticals Inc. (MIST)
Newly released Crypto mining rig for Milestone Pharmaceuticals Inc. coins
minutes ago | Banggood.com
Everything Crypto on sale now!
58 minutes ago | Aliexpress.com
Milestone Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Clinical and Corporate Update
3 days ago | PRNewsWire
Milestone Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference
2 months ago | PRNewsWire
Milestone Pharma-Ji Xing Pharma Ink $127M Etripamil Development Agreement For China
3 months ago | Benzinga
Milestone Pharmaceuticals Announces Late-Breaker Oral Presentation of NODE-301 Data at ACC.21
3 months ago | PRNewsWire
Milestone Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Clinical, Regulatory, and Corporate Update
3 months ago | PRNewsWire
Milestone Pharmaceuticals Announces Exclusive License Agreement with Ji Xing Pharmaceuticals to Develop and Commercialize Etripamil for PSVT in Greater China
3 months ago | PRNewsWire
Milestone Pharmaceuticals Stock Is a Bet On Etripamil
4 months ago | InvestorPlace
Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Clinical and Corporate Update
4 months ago | PRNewsWire
Milestone Pharmaceuticals Announces First Patient Enrolled in the ReVeRA Study, its Phase 2 Trial of Etripamil in Atrial Fibrillation and Rapid Ventricular Rate
4 months ago | PRNewsWire
Milestone Pharmaceuticals to Present at Upcoming Investor Conferences
5 months ago | PRNewsWire

About:

Milestone Pharmaceuticals Inc., a biopharmaceutical company, develops and commercializes etripamil for the treatment of cardiovascular indications. It is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada, as well as for the treatment of atrial fibrillation, angina, and other cardiovascular indications. The company was founded in 2003 and is headquartered in Montréal, Canada.

Sector:

Healthcare

Industry:

Biotechnology

Employees:

28

Address:

Milestone Pharmaceuticals Inc. 1111 Dr. Frederik-Philips Boulevard Suite 420 Montreal QC H4M 2X6 Canada

Website:

Home

Phone:

514-336-0444

Leave a comment

Your email address will not be published. Required fields are marked *